ArticleBioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy2024

Charting the Etanercept Journey: Tracing Cost Dynamics in Poland's Off-Patent Market from Reference Drug Rivalry to Biosimilar Monopoly.

Marcin Stajszczyk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.